Results for tag: "Cardiovascular Inflammation Drug"

The Cardiovascular Inflammation Drug market is a subset of the larger Cardiovascular Drugs market. It focuses on drugs that are used to treat inflammation of the cardiovascular system, such as atherosclerosis, coronary artery disease, and congestive heart failure. These drugs are typically used to reduce inflammation, improve blood flow, and reduce the risk of heart attack and stroke. Commonly used drugs in this market include statins, ACE inhibitors, and anti-inflammatory drugs. The Cardiovascular Inflammation Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in this market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. Show Less Read more